Search

Your search keyword '"Idilman, Ramazan"' showing total 695 results
Start Over Author "Idilman, Ramazan"
695 results on '"Idilman, Ramazan"'

1. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone

Author

Duman, Serkan, Kuru, Digdem, Gumussoy, Mesut, Kiremitci, Saba, Gokcan, Hale, Ulas, Bahar, Ellik, Zeynep, Ozercan, Mubin, Er, Ramazan Erdem, Karakaya, Fatih, Bodakci, Emin, Erden, Ayse, Elhan, Atilla H., Savas, Berna, Loomba, Rohit, and Idilman, Ramazan

Published
2024
Full Text
View/download PDF

2. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis

Author

Huang, Daniel Q, Noureddin, Nabil, Ajmera, Veeral, Amangurbanova, Maral, Bettencourt, Ricki, Truong, Emily, Gidener, Tolga, Siddiqi, Harris, Majzoub, Abdul M, Nayfeh, Tarek, Tamaki, Nobuharu, Izumi, Namiki, Yoneda, Masato, Nakajima, Atsushi, Idilman, Ramazan, Gumussoy, Mesut, Oz, Digdem Kuru, Erden, Ayse, Allen, Alina M, Noureddin, Mazen, and Loomba, Rohit

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Cancer, Diabetes, Liver Disease, Chronic Liver Disease and Cirrhosis, Rare Diseases, Digestive Diseases, Clinical Research, Liver Cancer, Aetiology, 2.1 Biological and endogenous factors, Metabolic and endocrine, Good Health and Well Being, Adult, Humans, Female, Adolescent, Middle Aged, Male, Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2, Liver Neoplasms, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage, Clinical sciences
Abstract

BackgroundData are scarce regarding the development of hepatic decompensation in patients with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes. We aimed to assess the risk of hepatic decompensation in people with NAFLD with and without type 2 diabetes.MethodsWe did a meta-analysis of individual participant-level data from six cohorts in the USA, Japan, and Turkey. Included participants had magnetic resonance elastography between Feb 27, 2007, and June 4, 2021. Eligible studies included those with liver fibrosis characterisation by magnetic resonance elastography, longitudinal assessment for hepatic decompensation and death, and included adult patients (aged ≥18 years) with NAFLD, for whom data were available regarding the presence of type 2 diabetes at baseline. The primary outcome was hepatic decompensation, defined as ascites, hepatic encephalopathy, or variceal bleeding. The secondary outcome was the development of hepatocellular carcinoma. We used competing risk regression using the Fine and Gray subdistribution hazard ratio (sHR) to compare the likelihood of hepatic decompensation in participants with and without type 2 diabetes. Death without hepatic decompensation was a competing event.FindingsData for 2016 participants (736 with type 2 diabetes; 1280 without type 2 diabetes) from six cohorts were included in this analysis. 1074 (53%) of 2016 participants were female with a mean age of 57·8 years (SD 14·2) years and BMI of 31·3 kg/m2 (SD 7·4). Among 1737 participants (602 with type 2 diabetes and 1135 without type 2 diabetes) with available longitudinal data, 105 participants developed hepatic decompensation over a median follow-up time of 2·8 years (IQR 1·4-5·5). Participants with type 2 diabetes had a significantly higher risk of hepatic decompensation at 1 year (3·37% [95% CI 2·10-5·11] vs 1·07% [0·57-1·86]), 3 years (7·49% [5·36-10·08] vs 2·92% [1·92-4·25]), and 5 years (13·85% [10·43-17·75] vs 3·95% [2·67-5·60]) than participants without type 2 diabetes (p

Published
2023

3. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants

Author

Ajmera, Veeral, Kim, Beom Kyung, Yang, Kun, Majzoub, Abdul M, Nayfeh, Tarek, Tamaki, Nobuharu, Izumi, Namiki, Nakajima, Atsushi, Idilman, Ramazan, Gumussoy, Mesut, Oz, Digdem Kuru, Erden, Ayse, Quach, Natalie E, Tu, Xin, Zhang, Xinlian, Noureddin, Mazen, Allen, Alina M, and Loomba, Rohit

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Liver Disease, Clinical Research, Digestive Diseases, Chronic Liver Disease and Cirrhosis, Oral and gastrointestinal, Good Health and Well Being, Adult, Aged, Biomarkers, Carcinoma, Hepatocellular, Elasticity Imaging Techniques, Female, Fibrosis, Humans, Liver, Liver Cirrhosis, Liver Neoplasms, Magnetic Resonance Imaging, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Portal Hypertension, Cirrhosis, Ascites, Varices, Neurosciences, Paediatrics and Reproductive Medicine, Gastroenterology & Hepatology, Clinical sciences, Nutrition and dietetics
Abstract

Background & aimsMagnetic resonance elastography (MRE) is an accurate biomarker of liver fibrosis; however, limited data characterize its association with clinical outcomes. We conducted an individual participant data pooled meta-analysis on patients with nonalcoholic fatty liver disease to evaluate the association between liver stiffness on MRE and liver-related outcomes.MethodsA systematic search identified 6 cohorts of adults with nonalcoholic fatty liver disease who underwent a baseline MRE and were followed for hepatic decompensation, hepatocellular carcinoma, and death. Cox and logistic regression were used to assess the association between liver stiffness on MRE and liver-related outcomes, including a composite primary outcome defined as varices needing treatment, ascites, and hepatic encephalopathy.ResultsThis individual participant data pooled meta-analysis included 2018 patients (53% women) with a mean (± standard deviation) age of 57.8 (±14) years and MRE at baseline of 4.15 (±2.19) kPa, respectively. Among 1707 patients with available longitudinal data with a median (interquartile range) of 3 (4.2) years of follow-up, the hazard ratio for the primary outcome for MRE of 5 to 8 kPa was 11.0 (95% confidence interval [CI]: 7.03-17.1, P < .001) and for ≥ 8 kPa was 15.9 (95% CI: 9.32-27.2, P < .001), compared with those with MRE

Published
2022

4. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Author

Kumar, Shiva, Gadano, Adrián, Marciano, Sebastián, Tudehope, Fiona, Prudence, Alexander, Gibson, Robert, Zekry, Amany, Doyle, Adam, Si, Hooi Ling, Kim, Yu Sung, Gofton, Cameron, Riordan, Stephen, MacQuillan, Gerry, Al-Tamimi, Hala, Michalczuk, Matheus, Farias, Alberto, Zitelli, Patricia, Pereira, Gustavo, Victor, Livia, Bera, Chinmay, Faisal, Nabiha, Dahiya, Monica, Tandon, Puneeta, Lohoues, Marie Jeanne, Lah, Ponan Claude Regis, Benítez, Carlos, Arrese, Marco, Guan, Jing, Xian, Yongchao, Zhu, Chuanwu, Wang, Yingling, Su, Man, Su, Minghua, Wang, Xinrui, Gao, Yanhang, Peng, Feng, Jiang, Yongfang, Zhao, Caiyan, Wang, Wei, Yin, Dedong, Wang, Lei, Lu, Mingqin, Cai, Yijing, Guo, Feng, Wang, Xiaozhong, Zhang, Ningping, Zhang, Wanqin, Dong, Fuchen, Li, Hai, Liu, Jing, Zheng, Xin, Tang, Hong, Yan, Libo, Xu, Bin, Wei, Linlin, Xu, Zhen, Gao, Zhiliang, Gao, Haibing, Lin, Minghua, Rao, Qunfang, Wu, Xiaoping, Li, Beiling, Chen, Jinjun, Liu, Chenghai, Zhang, Yanyun, Deng, Huan, Hu, Peng, Wang, Jian, Li, Jie, Bettinger, Dominik, Schultheiß, Michael, Belimi, Hibat Allah, Debzi, Nabil, Mostafa, Alaa, Fouad, Yasser, Fisseha, Henok, Venkatachalapathy, Suresh Vasan, Aravinthan, Aloysious D, Rajoriya, Neil, Faulkes, Rosemary, Leith, Damien, Forrest, Ewan, Danielle, Adebayo, Kennedy, James, Yung, Diana, Alexopoulou, Alexandra, Mani, Iliana, Fung, James, Katchman, Helena, Rabinowich, Liane, Jhaveri, Ajay, Nagral, Aabha, Kulkarni, Anand, Sharma, Mithun, Sarin, Shiv K, Goel, Ashish, Eapen, C E, Duseja, Ajay, Gandotra, Akash, Saraya, Anoop, yegurla, Jatin, Jothimani, Dinesh, Rela, Mohammad, Arora, Anil, Kumar, Ashish, Roy, Akash, Dhiman, R K, Anand, A C, Praharaj, Dibyalochan, Cabrera, Araceli Bravo, Hueso, Sarai Gonzalez, Hérnandez, José Luis Pérez, Gutierrez, Oscar Morales, Ramos-Pineda, Abraham, Zazueta, Godolfino Miranda, Barradas, Mauricio Castillo, Made, Lilian Torres, Velazquez, Rene Male, Félix-Tellez, Francisco, Velasco, José Antonio Velarde-Ruiz, Cordova-Gallardo, Jacqueline, Rajaram, Ruveena, Afendi, Nik Arsyad Nik Muhamad, Nyam, David P, Okeke, Edith N, Allam, Dalia, Patwa, Yashwi Haresh Kumar, Tan, Hiang Keat, Lun, Liou Wei, Ho, Wei Ling Danielle, Wong, Yu Jun, Thanapirom, Kessarin, Teerasarntipan, Tongluk, Haktaniyan, Busra, Gunduz, Feyza, Aslan, Rahmi, Yildirim, Abdullah Emre, Barutcu, Sezgin, Uysal, Alper, Karasu, Zeki, Ucbilek, Enver, Kosay, Tolga, Dinçer, Dinç, Adanır, Haydar, Albhaisi, Somaya, Fallahadeh, Mohammad Amin, Asrani, Sumeet, Reddy, K Rajender, Shaw, Jawaid, Vargas, Hugo, Filipek, Natalia, Biggins, Scott W, Thuluvath, Paul, Sheshadri, Somya, Wegermann, Kara, Kappus, Matthew, Keaveny, Andrew, Rojo, Andres, Negrillo, Ricardo Cabello, Verna, Elizabeth, Cao, Zhujun, Wong, Florence, Choudhury, Ashok K, Kamath, Patrick S, Topazian, Mark, Torre, Aldo, Hayes, Peter C, George, Jacob, Idilman, Ramazan, Seto, Wai-Kay, Desalegn, Hailemichael, Alvares-da-Silva, Mario Reis, Bush, Brian J, Thacker, Leroy R, Xie, Qing, and Bajaj, Jasmohan S

Published
2024
Full Text
View/download PDF

7. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Author

Bruzone, Santiago Oscar, Coronel, Maria Jimena, Gruz, Fernando M., MacKinnon, Ignacio, George, Jacob, Muller, Kate, Lee, Samuel S., Caussy, Cyrielle, Petit, Jean Michel, Ari, Ziv Ben, Braun, Marius, Katchman, Helena, Lurie, Yoav, Veitsman, Ella, Zuckerman, Eli, Aghemo, Alessio, Basili, Stenfania, Fracanzani, Anna Ludovica, Pietrangelo, Antonello, Sacerdoti, David, Rubio Arce, Jose Francisco, de Guevara Cetina, Alma Laura Ladron, Chavez-Tapia, Norberto Carlos, Reyes, Eira Cerda, Pinzon Te, Lourdes Lol-Be, Baker, John R., Ngu, Jeffrey, Orr, David, Janczewska, Ewa, Matusik, Pawel, Stanislaw Sadurski, Maciej Murawski, Akinina, Anna Valerievna, Alpenidze, Diana Nodarievna, Bogomolov, Pavel, Ermakova, Polina Yurievna, Golovach, Albina V., Kim, Sang Gyune, Lee, Jin-Woo, Paik, Yong Han, Park, Jun Yong, Yeon, Jong Eun, Blasco, Victor Vargas, Madueno, Francisco Jose Tinahones, Panero, Jose Luis Calleja, Perez, Esther Molina, Romero-Gómez, Manuel, Cheng, Pin-Nan, Jeng, Wen-Juei, Liu, Chun-Jen, Akyuz, Filiz, Balaban, Hatice Yasemin, Basaranoglu, Metin, Demir, Tevfik, Idilman, Ramazan, Karakan, Tarkan, Gyrina, Olga, Kolesnikova, Olena Vadimivna, Pyvovar, Sergiy M., Oliinyk, Oleksandr, Skrypnyk, Igor, Bassan, Isaac, Bowman, William Kelly, Denham, Douglas Scott, Ghalib, Reem, Lawitz, Eric J., Lucas, Kathryn Jean, Mohseni, Rizwana H., Sanchez, William Eduardo, Vierling, John Moore, Lawitz, Eric, Shankar, R. Ravi, Chaudhri, Eirum, Liu, Jie, Lam, Raymond L.H., Kaufman, Keith D., and Engel, Samuel S.

Published
2023
Full Text
View/download PDF

8. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Author

Bourgeois, Stefan, Vanwolleghem, Thomas, Nevens, Frederik, Horsmans, Yves, Van Vlierberghe, Hans, Nastri, Ana Catharina, Lacerda, Marcus, Ramji, Alnoor, Conway, Brian, Coffin, Carla, Janssen, Harry, Fung, Scott, Shafran, Stephen, Hou, Jin Lin, Sperl, Jan, Urbanek, Petr, Plisek, Stanislav, Hejda, Vaclav, Samuel, Didier, Lacombe, Karine, Zoulim, Fabien, Guyader, Dominique, Raffi, Francois, Asselah, Tarik, Bourliere, Marc, Hilleret, Marie-Noelle, Wedemeyer, Heiner, Schulze zur Wiesch, Julian, Sprinzl, Kathrin, van Boemmel, Florian, Hilgard, Gudrun, Sabranski, Michael, Arasteh, Keikawus, Chan, Henry LY, Yuen, Man Fung, Wong, Vincent Ws, Brunetto, Maurizia Rossana, Taliani, Gloria, Andreone, Pietro, Lampertico, Pietro, Kurosaki, Masayuki, Yatsuhashi, Hiroshi, Fujiwara, Kei, Takehara, Tetsuo, Kawaoka, Tomokazu, Asahina, Yasuhiro, Enomoto, Hirayuki, Yabushita, Kazuhisa, Notsumata, Kazuo, Takaguchi, Koichi, Kawabe, Naoto, Kato, Naoya, Koji, Ogawa, Namisaki, Tadashi, Suzuki, Yoshiyuki, Yoon, Jung-Hwan, Ahn, SangHoon, Lim, Young-Suk, Paik, Seung Woon, Kiew, Kuang Kiat, Mohamed, Rosmawati, Tan, Soek Siam, Lee, Yeong Yeh, Hlebowicz, Maria, Berak, Hanna, Gasiorowski, Jacek, Halota, Waldemar, Janczewska, Ewa, Geyvandova, Natalia, Morozov, Viacheslav, Andreeva, Alla, Gusev, Denis, Bessonova, Elena, Osipenko, Marina, Romanova, Svetlana, Gankina, Natalia, Sagalova, Olga, Stepanova, Tatiana, Crespo Garcia, Javier, Diago, Moises, Inmaculada, Fernandez, Calleja, Jose Luis, Forns, Xavier, Buti, Maria, Tangkijvanich, Pisit, Tanwandee, Tawesak, Piratvisuth, Teerha, Leerapun, Apinya, Yilmaz, Gurdal, Tabak, Ömer Fehmi, Akarca, Ulus Salih, Akova, Murat, Idilman, Ramazan, Forton, Daniel, Bell, David, Agarwal, Kosh, Kennedy, Patrick, Felizarta, Franco, Sulkowski, Mark, Nahass, Ronald, Rojter, Sergio, Jacobson, Ira, Korenblat, Kevin, Gitlin, Norman, Yuen, Man-Fung, Jacobson, Ira M, Janssen, Harry L A, Kakuda, Thomas N, Lambrecht, Tom, Beumont, Maria, Kalmeijer, Ronald, Guinard-Azadian, Carine, Mayer, Cristiana, Jezorwski, John, Verbinnen, Thierry, Lenz, Oliver, Shukla, Umesh, and Biermer, Michael

Published
2023
Full Text
View/download PDF

9. A global research priority agenda to advance public health responses to fatty liver disease

Author

Lazarus, Jeffrey V., Mark, Henry E., Allen, Alina M., Arab, Juan Pablo, Carrieri, Patrizia, Noureddin, Mazen, Alazawi, William, Alkhouri, Naim, Alqahtani, Saleh A., Arrese, Marco, Bataller, Ramon, Berg, Thomas, Brennan, Paul N., Burra, Patrizia, Castro-Narro, Graciela E., Cortez-Pinto, Helena, Cusi, Kenneth, Dedes, Nikos, Duseja, Ajay, Francque, Sven M., Hagström, Hannes, Huang, Terry T-K., Wajcman, Dana Ivancovsky, Kautz, Achim, Kopka, Christopher J., Krag, Aleksander, Miller, Veronica, Newsome, Philip N., Rinella, Mary E., Romero, Diana, Sarin, Shiv Kumar, Silva, Marcelo, Spearman, C. Wendy, Tsochatzis, Emmanuel A., Valenti, Luca, Villota-Rivas, Marcela, Zelber-Sagi, Shira, Schattenberg, Jörn M., Wong, Vincent Wai-Sun, Younossi, Zobair M., Aberg, Fredrik, Adams, Leon, Al-Naamani, Khalid, Albadawy, Reda M., Alexa, Zinaida, Allison, Michael, Alnaser, Faisal A., Alswat, Khalid, Alvares-da-Silva, Mario Reis, Alvaro, Domenico, Alves-Bezerra, Michele, Andrade, Raul J., Anstee, Quentin M., Awuku, Yaw Asante, Baatarkhuu, Oidov, Baffy, Gyorgy, Bakieva, Shokhista, Bansal, Meena B., Barouki, Robert, Batterham, Rachel L., Behling, Cynthia, Belfort-DeAguiar, Renata, Berzigotti, Annalisa, Betel, Michael, Bianco, Cristiana, Bosi, Emanuele, Boursier, Jerome, Brunt, Elizabeth M., Bugianesi, Elisabetta, Byrne, Christopher J., Cabrera Cabrejos, Maria Cecilia, Caldwell, Stephen, Carr, Rotonya, Castellanos Fernández, Marlen Ivón, Castera, Laurent, Castillo-López, Maria Gabriela, Caussy, Cyrielle, Cerda-Reyes, Eira, Ceriello, Antonio, Chan, Wah- Kheong, Chang, Yoosoo, Charatcharoenwitthaya, Phunchai, Chavez-Tapia, Norberto, Chung, Raymond T., Colombo, Massimo, Coppell, Kirsten, Cotrim, Helma P., Craxi, Antonio, Crespo, Javier, Dassanayake, Anuradha, Davidson, Nicholas O., De Knegt, Robert, de Ledinghen, Victor, Demir, Münevver, Desalegn, Hailemichael, Diago, Moises, Dillon, John F., Dimmig, Bruce, Dirac, M. Ashworth, Dirchwolf, Melisa, Dufour, Jean-François, Dvorak, Karel, Ekstedt, Mattias, El-Kassas, Mohamed, Elsanousi, Osama M., Elsharkawy, Ahmed M., Elwakil, Reda, Eskridge, Wayne, Eslam, Mohammed, Esmat, Gamal, Fan, Jian- Gao, Ferraz, Maria Lucia, Flisiak, Robert, Fortin, Davide, Fouad, Yasser, Freidman, Scott L., Fuchs, Michael, Gadano, Adrian, Gastaldelli, Amalia, Geerts, Anja, Geier, Andreas, George, Jacob, Gerber, Lynn H., Ghazinyan, Hasmik, Gheorghe, Liana, Kile, Denise Giangola, Girala, Marcos, Boon Bee, George Goh, Goossens, Nicolas, Graupera, Isabel, Grønbæk, Henning, Hamid, Saeed, Hebditch, Vanessa, Henry, Zachary, Hickman, Ingrid J., Hobbs, L. Ansley, Hocking, Samantha L., Hofmann, Wolf Peter, Idilman, Ramazan, Iruzubieta, Paula, Isaacs, Scott, Isakov, Vasily A., Ismail, Mona H., Jamal, Mohammad H., Jarvis, Helen, Jepsen, Peter, Jornayvaz, François, Sudhamshu, K.C., Kakizaki, Satoru, Karpen, Saul, Kawaguchi, Takumi, Keating, Shelley E., Khader, Yousef, Kim, Seung Up, Kim, Won, Kleiner, David E., Koek, Ger, Joseph Komas, Narcisse Patrice, Kondili, Loreta A., Koot, Bart G., Korenjak, Marko, Kotsiliti, Eleni, Koulla, Yiannoula, Kugelmas, Carina, Kugelmas, Marcelo, Labidi, Asma, Lange, Naomi F., Lavine, Joel E., Lazo, Mariana, Leite, Nathalie, Lin, Han-Chieh, Lkhagvaa, Undram, Long, Michelle T., Lopez-Jaramillo, Patricio, Lozano, Adelina, Macedo, Maria Paula, Malekzadeh, Reza, Marchesini, Giulio, Marciano, Sebastian, Martinez, Kim, Martínez Vázquez, Sophia E., Mateva, Lyudmila, Mato, José M., Nlombi, Charles Mbendi, McCary, Alexis Gorden, McIntyre, Jeff, McKee, Martin, Mendive, Juan M., Mikolasevic, Ivana, Miller, Pamela S., Milovanovic, Tamara, Milton, Terri, Moreno-Alcantar, Rosalba, Morgan, Timothy R., Motala, Ayesha, Muris, Jean, Musso, Carla, Nava-González, Edna J., Negro, Francesco, Nersesov, Alexander V., Neuschwander-Tetri, Brent A., Nikolova, Dafina, Norris, Suzanne, Novak, Katja, Ocama, Ponsiano, Ong, Janus P., Ong-Go, Arlinking, Onyekwere, Charles, Padilla, Martin, Pais, Raluca, Pan, Calvin, Panduro, Arturo, Panigrahi, Manas K., Papatheodoridis, Georgios, Paruk, Imran, Patel, Keyur, Gonçalves, Carlos Penha, Figueroa, Marlene Pérez, Pérez-Escobar, Juanita, Pericàs, Juan M., Perseghin, Gianluca, Pessoa, Mário Guimarães, Petta, Salvatore, Marques Souza de Oliveira, Claudia Pinto, Prabhakaran, Dorairaj, Pyrsopoulous, Nikolaos, Rabiee, Atoosa, Ramji, Alnoor, Ratziu, Vlad, Ravendhran, Natarajan, Ray, Katrina, Roden, Michael, Romeo, Stefano, Romero-Gómez, Manuel, Rotman, Yaron, Rouabhia, Samir, Rowe, Ian A., Sadirova, Shakhlo, Alkhatry, Maryam Salem, Salupere, Riina, Satapathy, Sanjaya K., Schwimmer, Jeffrey B., Sebastiani, Giada, Seim, Lynn, Seki, Yosuke, Serme, Abdel Karim, Shapiro, David, Sharvadze, Lali, Shaw, Jonathan E., Shawa, Isaac Thom, Shenoy, Thrivikrama, Shibolet, Oren, Shimakawa, Yusuke, Shubrook, Jay H., Singh, Shivaram Prasad, Sinkala, Edford, Skladany, Lubomir, Skrypnyk, Igor, Song, Myeong Jun, Sookoian, Silvia, Sridharan, Kannan, Stefan, Norbert, Stine, Jonathan G., Stratakis, Nikolaos, Sheriff, Dhastagir Sultan, Sundaram, Shikha S., Svegliati-Baroni, Gianluca, Swain, Mark G., Tacke, Frank, Taheri, Shahrad, Tan, Soek-Siam, Tapper, Elliot B., Targher, Giovanni, Tcaciuc, Eugen, Thiele, Maja, Tiniakos, Dina, Tolmane, Ieva, Torre, Aldo, Torres, Esther A., Treeprasertsuk, Sombat, Trenell, Michael, Turcan, Svetlana, Turcanu, Adela, Valantinas, Jonas, van Kleef, Laurens A., Velarde Ruiz Velasco, Jose Antonio, Vesterhus, Mette, Vilar-Gomez, Eduardo, Waked, Imam, Wattacheril, Julia, Wedemeyer, Heiner, Wilkins, Fonda, Willemse, José, Wong, Robert J., Yilmaz, Yusuf, Yki-Järvinen, Hannele, Yu, Ming-Lung, Yumuk, Volkan, Zeybel, Müjdat, Zheng, Kenneth I., Zheng, Ming-Hua, and Huang, Terry T.-K.

Published
2023
Full Text
View/download PDF

10. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Author

Sarin, Shiv K, Kumar, Shiva, Marciano, Sebastián, Gadano, Adrián, Tudehope, Fiona, Gibson, Robert, Prudence, Alexander, Doyle, Adam, Si, Hooi Ling, Riordan, Stephen, Farias, Alberto, Zitelli, Patricia, Bera, Chinmay, Faisal, Nabiha, Tandon, Puneeta, Dahiya, Monica, Lohoues, Marie Jeanne, Lah, Ponan Claude Regis, Benítez, Carlos, Arrese, Marco, Xian, Yongchao, Guan, Jin, Zhu, Chuanwu, Wang, Yingling, Su, Minghua, Su, Man, Gao, Yanhang, Wang, Xinrui, Jiang, Yongfang, Peng, Feng, Zhao, Caiyan, Wang, Wei, Wang, Lei, Yin, Dedong, Lu, Mingqin, Cai, Yijing, Zhang, Ningping, Zhang, Wanqin, Li, Hai, Dong, Fuchen, Zheng, Xin, Liu, Jing, Tang, Hong, Yan, Libo, Xu, Bin, Wei, Linlin, Gao, Zhiliang, Xu, Zhen, Lin, Minghua, Gao, Haibin, Chen, Jinjun, Li, Beiling, Liu, Chenghai, Zhang, Yanyun, Hu, Peng, Deng, Huan, Belimi, Hibat Allah, Debzi, Nabil, Fisseha, Henok, Aravinthan, Aloysious D, Venkatachalapathy, Suresh Vasan, Rajoriya, Neil, Faulkes, Rosemary, Leith, Damien, Forrest, Ewan, Adebayo, Danielle, Kennedy, James, Yung, Diana, Seto, Wai-Kay, Fung, James, Katchman, Helena, Rabinowich, Liane, Nagral, Aabha, Jhaveri, Ajay, Kulkarni, Anand, Sharma, Mithun, Eapen, C E, Goel, Ashish, Gandotra, Akash, Duseja, Ajay, Saraya, Anoop, Yegurla, Jatin, Rela, Mohamed, Jothimani, Dinesh, Arora, Anil, Kumar, Ashish, Dhiman, Radha Krishan, Roy, Akash, Anand, Anil C, Praharaj, Dibyalochan, Hueso, Sarai Gonzalez, Cabrera, Araceli Bravo, Pérez Hérnandez, José Luis, Gutierrez, Oscar Morales, Miranda Zazueta, Godolfino, Ramos-Pineda, Abraham, Castillo Barradas, Mauricio, Velazquez, Rene Male, Made, Lilian Torres, Velarde-Ruiz Velasco, José Antonio, Félix-Tellez, Francisco, Cordova-Gallardo, Jacqueline, Rajaram, Ruveena, Nik Muhamad Afendi, Nik Arsyad, Okeke, Edith N, Nyam, David P, Allam, Dalia, Kumar Patwa, Yashwi Haresh, Tan, Hiang Keat, Liou, Wei Lun, Treeprasertsuk, Sombat, Wejnaruemarn, Salisa, Haktaniyan, Busra, Gunduz, Feyza, Aslan, Rahmi, Yildirim, Abdullah Emre, Barutcu, Sezgin, Karasu, Zeki, Uysal, Alper, Ucbilek, Enver, Kosay, Tolga, Adanir, Haydar, Dinçer, Dinç, Albhaisi, Somaya, Asrani, Sumeet, Fallahadeh, Mohammad Amin, Reddy, K Rajender, Rahematpura, Suditi, Shaw, Jawaid, Vargas, Hugo E., Bayne, David, Biggins, Scott W, Filipek, Natalia, Thuluvath, Paul, Sheshadri, Somya, Keaveny, Andrew, Duarte Rojo, Andres, Cabello Negrillo, Ricardo, Bajaj, Jasmohan S, Choudhury, Ashok K, Xie, Qing, Kamath, Patrick S, Topazian, Mark, Hayes, Peter C, Torre, Aldo, Desalegn, Hailemichael, Idilman, Ramazan, Cao, Zhujun, Alvares-da-Silva, Mario R, George, Jacob, Bush, Brian J, Thacker, Leroy R, and Wong, Florence

Published
2023
Full Text
View/download PDF

11. FRI-088 Patterns and predictors of postacute discharge location other than home in a global cohort of 3, 678 patients hospitalized with cirrhosis

Author

Seto, Wai-Kay, primary, Xie, Qing, additional, Kumar Choudhury, Ashok, additional, Kamath, Patrick S., additional, Topazian, Mark, additional, Hayes, Peter, additional, Torre, Aldo, additional, Desalegn, Hailemichael, additional, Idilman, Ramazan, additional, Cao, Zhujun, additional, Álvares-da-Silva, Mario, additional, George, Jacob, additional, Wong, Florence, additional, Bush, Brian, additional, Thacker, Leroy, additional, Kumar Sarin, Shiv, additional, Mani, Iliana, additional, Dincer, Dinc, additional, van Doorn, Diederick, additional, Sonavane, Amey, additional, Amin Fallahzadeh, Mohammad, additional, Wei, Linlin, additional, Bravo Cabrera, Araceli, additional, Goel, Ashish, additional, Ponan Claude Regis Lah, Ponan, additional, Kumar, Shiva, additional, Jun Wong, Yu, additional, Jothimani, Dinesh, additional, Robert Kappus, Matthew, additional, Emre Yıldırım, Abdullah, additional, H Forrest, Ewan, additional, Félix Tellez, Francisco, additional, Momoyo Zitelli, Patricia, additional, Barbero, Manuel, additional, Luis Pérez-Hernández, José, additional, Marciano, Sebastián, additional, Malé Velazquez, René, additional, Jhaveri, Ajay, additional, Gibson, Robert, additional, Chandra Anand, Anil, additional, Kayes, Tahrima, additional, Gunduz, Feyza, additional, Bayne, David, additional, Lin, Minghua, additional, Ucbilek, Enver, additional, Debzi, Nabil, additional, Wang, Jian, additional, Haresh Kumar Patwa, Yashwi, additional, Kumar Duseja, Ajay, additional, Arrese, Marco, additional, Faulkes, Rosemary, additional, Kennedy, James, additional, Sung Kim, Yu, additional, Krishan Dhiman, Radha, additional, Li, Hai, additional, Yin, Dedong, additional, Zhang, Yanyun, additional, MacQuillan, Gerry, additional, Kumar, Ashish, additional, Katchman, Helena, additional, Wang, Yingling, additional, Rao, Qunfang, additional, Cai, Yijing, additional, Wu, Liyang, additional, Jiang, Yongfang, additional, Xu, Zhen, additional, Xian, Yongchao, additional, Bettinger, Dominik, additional, Dahiya, Monica, additional, Faisal, Nabiha, additional, Rojo Andres, Duarte, additional, Filipek, Natalia, additional, Tudehope, Fiona, additional, Zhang, Wanqin, additional, and Bajaj, Jasmohan, additional

Published
2024
Full Text
View/download PDF

12. THU-171 Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry

Author

Adali, Gupse, primary, Harputluoglu, Murat, additional, Kayhan, Meral Akdogan, additional, Gökçe, Dilara Turan, additional, Akarsu, Mesut, additional, Daniş, Nilay, additional, Dincer, Dinc, additional, Adanir, Haydar, additional, Turan, Ilker, additional, Isik, Elvan, additional, Gokcan, Hale, additional, Yılmaz, Volkan, additional, İstemihan, Zülal, additional, Kaymakoğlu, Sabahattin, additional, Idilman, Ramazan, additional, and Karasu, Zeki, additional

Published
2024
Full Text
View/download PDF

13. SAT-519 The impact of tumor budding on tumor biology in patients with hepatocellular carcinoma

Author

Duran, Osman Fırat, primary, Gokcan, Hale, additional, Kiremitçi, Saba, additional, Aras, Nermin, additional, Karayel, Sevınc Tugce, additional, Yılmaz, Volkan, additional, Çiftçi, Aslı, additional, Bodakçi, Emin, additional, Gumussoy, Mesut, additional, Ellik, Zeynep Melekoğlu, additional, Özercan, Abdullah Mübin, additional, Duman, Serkan, additional, Savaş, Berna, additional, and Idilman, Ramazan, additional

Published
2024
Full Text
View/download PDF

15. Assessing hepatic steatosis by magnetic resonance in potential living liver donors.

Author

Öz, Diğdem Kuru, Ellik, Zeynep, Çoruh, Ayşegül Gürsoy, Adıgüzel, Mehmet, Gümüşsoy, Mesut, Kiremitci, Saba, Kırımker, Elvan Onur, Gökcan, Hale, Elhan, Atilla Halil, Balcı, Deniz, Savaş, Berna, Erden, Ayşe, and İdilman, Ramazan

Subjects
NUCLEAR magnetic resonance spectroscopy, FATTY liver, MAGNETIC resonance imaging, RECEIVER operating characteristic curves, LIVER biopsy
Abstract

To determine the accuracy of magnetic resonance imaging-proton density fat fraction (MRI-PDFF) measurements for detecting liver fat content in potential living liver donors and to compare these results using liver biopsy findings. METHODS A total of 139 living liver donors (men/women: 83/56) who underwent MRI between January 2017 and September 2021 were included in this analysis retrospectively. The PDFFs were measured using both MR spectroscopy (MRS) and chemical shift-based MRI (CS-MRI) for each donor in a blinded manner. RESULTS Significant positive correlations were found between liver biopsy and MRS-PDFF and CS-MRI PDFF in terms of hepatic steatosis detection [r = 0.701, 95% confidence interval (CI): 0.604-0.798, r = 0.654, 95% CI: 0.544-0.765, P < 0.001, respectively). A weak level correlation was observed between liver biopsy, MRI methods, and vibration-controlled transient elastography attenuation parameters in 42 available donors. Based on receiver operating characteristic (ROC) analysis, MRS-PDFF and CSMRI PDFF significantly distinguished >5% of histopathologically detected hepatic steatosis with an area under the ROC curve (AUC) of 0.837 ± 0.036 (P < 0.001, 95% CI: 0.766-0.907) and 0.810 ± 0.036 (P < 0.001, 95% CI: 0.739-0.881), respectively. The negative predictive values (NPVs) of MRS-PDFF and CS-MRI PDFF were 88.3% and 81.3%, respectively. In terms of distinguishing between clinically significant hepatic steatosis (≥10% on histopathology), the AUC of MRS-PDFF and CS-MRI were 0.871 ± 0.034 (P < 0.001 95% CI: 0.804-0.937) and 0.855 ± 0.036 (P < 0.001, 95% CI: 0.784-0.925), respectively. The NPVs of MRS-PDFF and CS-MRI were 99% and 92%, respectively. CONCLUSION The methods of MRS-PDFF and CS-MRI PDFF provide a non-invasive and accurate approach for assessing hepatic steatosis in potential living liver donor candidates. These MRI PDFF techniques present a promising clinical advantage in the preoperative evaluation of living liver donors by eliminating the requirement for invasive procedures like liver biopsy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Assessing hepatic steatosis by magnetic resonance in potential living liver donors

Author

Kuru Öz, Diğdem, primary, Ellik, Zeynep, additional, Gürsoy Çoruh, Ayşegül, additional, Adıgüzel, Mehmet, additional, Gümüşsoy, Mesut, additional, Kiremitci, Saba, additional, Kırımker, Onur Elvan, additional, Gökcan, Hale, additional, Elhan, Atilla Halil, additional, Balcı, Deniz, additional, Savaş, Berna, additional, Erden, Ayşe, additional, and İdilman, Ramazan, additional

Published
2024
Full Text
View/download PDF

19. Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B

Author

Papatheodoridis, George V., Dalekos, George N., Idilman, Ramazan, Sypsa, Vana, Van Boemmel, Florian, Buti, Maria, Calleja, Jose Luis, Goulis, John, Manolakopoulos, Spilios, Loglio, Alessandro, Papatheodoridi, Margarita, Gatselis, Nikolaos, Veelken, Rhea, Lopez-Gomez, Marta, Hansen, Bettina E., Savvidou, Savvoula, Kourikou, Anastasia, Vlachogiannakos, John, Galanis, Kostas, Yurdaydin, Cihan, Esteban, Rafael, Janssen, Harry L.A., Berg, Thomas, and Lampertico, Pietro

Published
2021
Full Text
View/download PDF

20. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Author

Cao, Zhujun, Wong, Florence, Choudhury, Ashok K, Kamath, Patrick S, Topazian, Mark, Torre, Aldo, Hayes, Peter C, George, Jacob, Idilman, Ramazan, Seto, Wai-Kay, Desalegn, Hailemichael, Alvares-da-Silva, Mario Reis, Bush, Brian J, Thacker, Leroy R, Xie, Qing, Bajaj, Jasmohan S, Kumar, Shiva, Gadano, Adrián, Marciano, Sebastián, Tudehope, Fiona, Prudence, Alexander, Gibson, Robert, Zekry, Amany, Doyle, Adam, Si, Hooi Ling, Kim, Yu Sung, Gofton, Cameron, Riordan, Stephen, MacQuillan, Gerry, Al-Tamimi, Hala, Michalczuk, Matheus, Farias, Alberto, Zitelli, Patricia, Pereira, Gustavo, Victor, Livia, Bera, Chinmay, Faisal, Nabiha, Dahiya, Monica, Tandon, Puneeta, Lohoues, Marie Jeanne, Lah, Ponan Claude Regis, Benítez, Carlos, Arrese, Marco, Guan, Jing, Xian, Yongchao, Zhu, Chuanwu, Wang, Yingling, Su, Man, Su, Minghua, Wang, Xinrui, Gao, Yanhang, Peng, Feng, Jiang, Yongfang, Zhao, Caiyan, Wang, Wei, Yin, Dedong, Wang, Lei, Lu, Mingqin, Cai, Yijing, Guo, Feng, Wang, Xiaozhong, Zhang, Ningping, Zhang, Wanqin, Dong, Fuchen, Li, Hai, Liu, Jing, Zheng, Xin, Tang, Hong, Yan, Libo, Xu, Bin, Wei, Linlin, Xu, Zhen, Gao, Zhiliang, Gao, Haibing, Lin, Minghua, Rao, Qunfang, Wu, Xiaoping, Li, Beiling, Chen, Jinjun, Liu, Chenghai, Zhang, Yanyun, Deng, Huan, Hu, Peng, Wang, Jian, Li, Jie, Bettinger, Dominik, Schultheiß, Michael, Belimi, Hibat Allah, Debzi, Nabil, Mostafa, Alaa, Fouad, Yasser, Fisseha, Henok, Venkatachalapathy, Suresh Vasan, Aravinthan, Aloysious D, Rajoriya, Neil, Faulkes, Rosemary, Leith, Damien, Forrest, Ewan, Danielle, Adebayo, Kennedy, James, Yung, Diana, Alexopoulou, Alexandra, Mani, Iliana, Fung, James, Katchman, Helena, Rabinowich, Liane, Jhaveri, Ajay, Nagral, Aabha, Kulkarni, Anand, Sharma, Mithun, Sarin, Shiv K, Goel, Ashish, Eapen, C E, Duseja, Ajay, Gandotra, Akash, Saraya, Anoop, yegurla, Jatin, Jothimani, Dinesh, Rela, Mohammad, Arora, Anil, Kumar, Ashish, Roy, Akash, Dhiman, R K, Anand, A C, Praharaj, Dibyalochan, Cabrera, Araceli Bravo, Hueso, Sarai Gonzalez, Hérnandez, José Luis Pérez, Gutierrez, Oscar Morales, Ramos-Pineda, Abraham, Zazueta, Godolfino Miranda, Barradas, Mauricio Castillo, Made, Lilian Torres, Velazquez, Rene Male, Félix-Tellez, Francisco, Velasco, José Antonio Velarde-Ruiz, Cordova-Gallardo, Jacqueline, Rajaram, Ruveena, Afendi, Nik Arsyad Nik Muhamad, Nyam, David P, Okeke, Edith N, Allam, Dalia, Patwa, Yashwi Haresh Kumar, Tan, Hiang Keat, Lun, Liou Wei, Ho, Wei Ling Danielle, Wong, Yu Jun, Thanapirom, Kessarin, Teerasarntipan, Tongluk, Haktaniyan, Busra, Gunduz, Feyza, Aslan, Rahmi, Yildirim, Abdullah Emre, Barutcu, Sezgin, Uysal, Alper, Karasu, Zeki, Ucbilek, Enver, Kosay, Tolga, Dinçer, Dinç, Adanır, Haydar, Albhaisi, Somaya, Fallahadeh, Mohammad Amin, Asrani, Sumeet, Reddy, K Rajender, Shaw, Jawaid, Vargas, Hugo, Filipek, Natalia, Biggins, Scott W, Thuluvath, Paul, Sheshadri, Somya, Wegermann, Kara, Kappus, Matthew, Keaveny, Andrew, Rojo, Andres, Negrillo, Ricardo Cabello, and Verna, Elizabeth

Abstract

Infections have a poor prognosis in inpatients with cirrhosis. We aimed to determine regional variations in infections and their association with clinical outcomes in a global cohort of inpatients with cirrhosis.

Published
2024
Full Text
View/download PDF

21. Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B

Author

Jang, Heejoon, Yoon, Jun Sik, Park, Soo Young, Lee, Han Ah, Jang, Myoung-jin, Kim, Seung Up, Sinn, Dong Hyun, Seo, Yeon Seok, Kim, Hwi Young, Kim, Sung Eun, Jun, Dae Won, Yoon, Eileen L., Sohn, Joo Hyun, Ahn, Sang Bong, Shim, Jae-Jun, Jeong, Soung Won, Cho, Yong Kyun, Kim, Hyoung Su, Nam, Joon Yeul, Lee, Yun Bin, Kim, Yoon Jun, Yoon, Jung-Hwan, Zoulim, Fabien, Lampertico, Pietro, Dalekos, George N., Idilman, Ramazan, Sypsa, Vana, Berg, Thomas, Buti, Maria, Calleja, Jose Luis, Goulis, John, Manolakopoulos, Spilios, Janssen, Harry LA., Papatheodoridis, George V., and Lee, Jeong-Hoon

Published
2021
Full Text
View/download PDF

22. A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis.

Author

Gokcan, Hale, Oz, Didem Kuru, Bodakci, Emin, Tunc, Esra, and Idilman, Ramazan

Subjects
HEMOCHROMATOSIS, GENETIC mutation, HOMOZYGOSITY, DISEASE prevalence, CIRRHOSIS of the liver
Abstract

Hereditary hemochromatosis (HH) is an autosomal recessive inherited iron-loading disorder and is characterized by chronic hepatitis, cirrhosis, diabetes, and bronze skin. The hemochromatosis gene (C282Y homozygosity)-related hemochromatosis is the most common form of HH. The prevalence of HH is varied. Here, we defined six cases with C282Y homozygosity-related HH in a single center in Turkiye. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease.

Author

Noureddin, Nabil, Huang, Daniel Q., Bettencourt, Ricki, Siddiqi, Harris, Majzoub, Abdul M., Nayfeh, Tarek, Tamaki, Nobuharu, Izumi, Namiki, Nakajima, Atsushi, Idilman, Ramazan, Gumussoy, Mesut, Oz, Digdem Kuru, Erden, Ayse, Gidener, Tolga, Allen, Alina M., Ajmera, Veeral, and Loomba, Rohit

Subjects
LIVER diseases, HEPATIC encephalopathy, TREATMENT effectiveness, SURVIVAL rate, LIVER transplantation
Abstract

Summary: Background & Aims: The natural progression of hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease (MASLD) is not well‐characterised. We aimed to describe it by conducting a retrospective analysis. Methods: This longitudinal, retrospective analysis of well‐characterised MASLD cohorts followed for hepatic decompensation and death. The sequence of liver‐related events was evaluated, and the median time between hepatic decompensation episodes and death versus. transplantation was measured. Results: Of the 2016 patients identified, 220 (11%) developed at least one episode of hepatic decompensation during a median follow‐up of 3.2 years. Ascites was the most common first liver‐related event [153 (69.5%)], followed by hepatic encephalopathy (HE) [55 (25%)] and variceal haemorrhage (VH) [30 (13.6%)]. Eighteen out of the 220 (8.1%) patients had more than one liver‐related event as their first hepatic decompensation. Among the patients who had the first episode, 87 (39.5%) had a second episode [44 (50.5%) HE, 31 (35.6%) ascites, and 12 (13.7%) VH]. Eighteen out of 220 (8.1%) had a third episode [10 (55.5%) HE, 6 (33.3%) VH, and 2 (11.1%) ascites]. Seventy‐three out of 220 (33.1%) died, and 31 (14%) received liver transplantation. The median time from the first episode to the second was 0.7 years and 1.3 years from the second episode to the third. The median survival time from the first episode to death or transplantation was 2.0 years. Conclusion: The most common first liver‐related event in MASLD patients is ascites. The median survival from the first hepatic decompensation to either death or transplantation is 2 years. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

Author

Wedemeyer, Heiner, Yurdaydin, Cihan, Hardtke, Svenja, Caruntu, Florin Alexandru, Curescu, Manuela G, Yalcin, Kendal, Akarca, Ulus S, Gürel, Selim, Zeuzem, Stefan, Erhardt, Andreas, Lüth, Stefan, Papatheodoridis, George V, Keskin, Onur, Port, Kerstin, Radu, Monica, Celen, Mustafa K, Idilman, Ramazan, Weber, Kristina, Stift, Judith, Wittkop, Ulrike, Heidrich, Benjamin, Mederacke, Ingmar, von der Leyen, Heiko, Dienes, Hans Peter, Cornberg, Markus, Koch, Armin, and Manns, Michael P

Published
2019
Full Text
View/download PDF

25. Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Author

Anastasiou, Olympia E., primary, Caruntu, Florin A., additional, Curescu, Manuela G., additional, Yalcin, Kendal, additional, Akarca, Ulus S., additional, Gürel, Selim, additional, Zeuzem, Stefan, additional, Erhardt, Andreas, additional, Lüth, Stefan, additional, Papatheodoridis, George V., additional, Keskin, Onur, additional, Port, Kerstin, additional, Radu, Monica, additional, Celen, Mustafa K., additional, Idilman, Ramazan, additional, Heidrich, Benjamin, additional, Mederacke, Ingmar, additional, von der Leyen, Heiko, additional, Kahlhöfer, Julia, additional, von Karpowitz, Maria, additional, Hardtke, Svenja, additional, Cornberg, Markus, additional, Yurdaydin, Cihan, additional, and Wedemeyer, Heiner, additional

Published
2023
Full Text
View/download PDF

27. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

Author

Papatheodoridis, George V., Sypsa, Vana, Dalekos, George, Yurdaydin, Cihan, van Boemmel, Florian, Buti, Maria, Goulis, John, Calleja, Jose Luis, Chi, Heng, Manolakopoulos, Spilios, Loglio, Alessandro, Siakavellas, Spyros, Gatselis, Nikolaos, Keskın, Onur, Lehretz, Maria, Savvidou, Savvoula, de la Revilla, Juan, Hansen, Bettina E., Kourikou, Anastasia, Vlachogiannakos, Ioannis, Galanis, Kostantinos, Idilman, Ramazan, Colombo, Massimo, Esteban, Rafael, Janssen, Harry L.A., Berg, Thomas, and Lampertico, Pietro

Published
2018
Full Text
View/download PDF

28. Availability and affordability of services affects outcome in hospitalized patients with cirrhosis-results from CLEARED consortium

Author

Choudhury, Ashok, primary, Xie, Qing, additional, Kamath, Patrick S., additional, Topazian, Mark, additional, Sarin, Shiv Kumar, additional, Hayes, Peter, additional, Torre, Aldo, additional, Desalegn, Hailemichael, additional, Idilman, Ramazan, additional, Cao, Zhujun, additional, Kumar, Shiva, additional, Gadano, Adrian, additional, Prudence, Alexander, additional, Zitelli, Patricia, additional, Bera, Chinmay, additional, Dahiya, Monica, additional, Regis Lah, Ponan Ponan Claude, additional, Arrese, Marco, additional, Guan, Jin, additional, Wang, Yingling, additional, Su, Man, additional, Wang, Xinrui, additional, Peng, Feng, additional, Wang, Wei, additional, Yin, Dedong, additional, Cai, Yijing, additional, dong, fuchen, additional, Liu, Jing, additional, Yan, Libo, additional, Wei, Linlin, additional, Xu, Zhen, additional, gao, haibing, additional, Li, Beiling, additional, Zhang, Yanyun, additional, Deng, Huan, additional, Debzi, Nabil, additional, Venkatachalapathy, Suresh Vasan, additional, Faulkes, Rosemary, additional, Forrest, Ewan, additional, Kennedy, James, additional, James Fung, Yan Yue, additional, Rabinowich, Liane, additional, Sharma, Mithun, additional, Yegurla, Jatin, additional, Jothimani, Dinesh, additional, Kumar, Ashish, additional, Goel, Ashish, additional, Roy, Akash, additional, Praharaj, Dibya Lochan, additional, Cabrera, Araceli Bravo, additional, Gutiérrez, Oscar Morales, additional, Pineda, Abraham Ramos, additional, Made, Lilian Torres, additional, Tellez, Francisco Félix, additional, Nik Arsyad, Nik MA, additional, David, Nyam P, additional, Kumar Patwa, Yashwi Haresh, additional, Lun, Liou Wei, additional, Wejnaruemarn, Salisa, additional, Haktaniyan, Busra, additional, Aslan, Rahmi, additional, Barutcu, Sezgin, additional, Uysal, Alper, additional, Kosay, Tolga, additional, Dincer, Dinc, additional, Fallahzadeh, Mohammad Amin, additional, Rahematpura, Suditi, additional, Bayne, David, additional, Filipek, Natalia, additional, Sheshadri, Somya, additional, Cabello, Ricardo, additional, Álvares-da-Silva, Mario, additional, George, Jacob, additional, Wong, Florence, additional, Bush, Brian, additional, Thacker, Leroy, additional, and Bajaj, Jasmohan S, additional

Published
2023
Full Text
View/download PDF

29. Identification of risk factors for alcohol relapse in liver transplant patients with alcohol-related liver disease

Author

Turan, Dilara, primary, Günsar, Fulya, additional, Harputluoglu, Murat, additional, Kabaçam, Gökhan, additional, Gokcan, Hale, additional, Akyildiz, Murat, additional, Akarsu, Mesut, additional, Adali, Gupse, additional, Ari, Derya, additional, Turan, Ilker, additional, Danis, Nilay, additional, Akarca, Ulus, additional, Durmazer, Esra, additional, Gencdal, Genco, additional, Aladag, Murat, additional, Gulsen, Murat Taner, additional, Sarikaya, Ozan, additional, Yılmaz, Volkan, additional, Karasu, Zeki, additional, Idilman, Ramazan, additional, and Kayhan, Meral Akdogan, additional

Published
2023
Full Text
View/download PDF

30. The role of PAGE-B score in predicting the development of hepatocelular cancer in patients with chronic delta hepatitis

Author

Keskin, Onur, primary, Kalkan, Cagdas, additional, Ozturk, Bengi, additional, Caliskan, Aysun, additional, Sahin, Hasan, additional, Gumussoy, Mesut, additional, Yurdcu, Esra, additional, Bozdayi, Mithat, additional, Akyildiz, Murat, additional, Zeybel, Mujdat, additional, Idilman, Ramazan, additional, and Yurdaydin, Cihan, additional

Published
2023
Full Text
View/download PDF

31. Development of metabolic disorders in transplant recipients

Author

Erdemir, Gizem, primary, Gokcan, Hale, additional, Çoruh, Ayşegül Gürsoy, additional, Gulpinar, Basak, additional, Ellik, Zeynep Melekoğlu, additional, Gümüşsoy, Mesut, additional, Duman, Serkan, additional, Bodakçi, Emin, additional, and Idilman, Ramazan, additional

Published
2023
Full Text
View/download PDF

32. Stratification of liver fat content in non-alcoholic steatohepatitis patients with significant liver fibrosis using the MEFIB-Index and MRI-PDFF and its association with hepatocellular carcinoma, decompensation, and mortality

Author

Lee, Sung Won, primary, Huang, Daniel, additional, Ajmera, Veeral, additional, Tincopa, Monica, additional, Bergstrom, Jaclyn, additional, Noureddin, Nabil, additional, Amangurbanova, Maral, additional, Siddiqi, Harris, additional, Madamba, Egbert, additional, Majzoub, Abdul, additional, Nayfeh, Tarek, additional, Tamaki, Nobuharu, additional, Izumi, Namiki, additional, Nakajima, Atsushi, additional, Idilman, Ramazan, additional, Gumussoy, Mesut, additional, Öz, Digdem Kuru, additional, Erden, Ayse, additional, Noureddin, Mazen, additional, and Loomba, Rohit, additional

Published
2023
Full Text
View/download PDF

33. Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study

Author

Bajaj, Jasmohan S, primary, Wong, Florence, additional, Xie, Qing, additional, Kamath, Patrick S., additional, Topazian, Mark, additional, Sarin, Shiv Kumar, additional, Kumar, Shiva, additional, Marciano, Sebastián, additional, Tudehope, Fiona, additional, Gibson, Robert, additional, Doyle, Adam, additional, Riordan, Stephen, additional, Farias, Alberto Queiroz, additional, Faisal, Nabiha, additional, Tandon, Puneeta, additional, Lohoues, Marie Jeanne, additional, Benitez, Carlos, additional, Xian, Yongchao, additional, Zhu, Chuanwu, additional, Su, Minghua, additional, Jiang, Yongfang, additional, Zhao, Caiyan, additional, Wang, Lei, additional, Lu, Mingqin, additional, Zhang, Ning-Ping, additional, Li, Hai, additional, Zheng, Xin, additional, Tang, Hong, additional, Xu, Bin, additional, gao, zhiliang, additional, Lin, minghua, additional, Chen, Jinjun, additional, Liu, ChengHai, additional, Hu, Peng, additional, Allah, Belimi Hibat, additional, Fisseha, Henok, additional, Aravinthan, Aloysious, additional, Rajoriya, Neil, additional, Leith, Damien, additional, Adebayo, Danielle, additional, Yung, Diana, additional, Seto, Wai-Kay, additional, Katchman, Helena, additional, Nagral, Abha, additional, Kulkarni, Anand, additional, Eapen, CE, additional, Duseja, Ajay Kumar, additional, Saraya, Anoop, additional, Rela, Mohd., additional, Anora, Anil, additional, Dhiman, Radha Krishan, additional, Anand, Anil Chandra, additional, González-Huezo, Maria Sarai, additional, Perez Hernandez, Jose Luis, additional, Zazueta, Godolfino Miranda, additional, Castillo, Mauricio, additional, Velazquez, René Malé, additional, Velarde-Ruiz Velasco, Jose Antonio, additional, Cordova, Jacqueline, additional, Bhavani, Ruveena, additional, Okeke, Edith, additional, Allam, Dalia, additional, Tan, Hiang Keat, additional, Treeprasertsuk, Sombat, additional, Haktaniyan, Busra, additional, Gunduz, Feyza, additional, Yıldırım, Abdullah Emre, additional, Karasu, Zeki, additional, Ucbilek, Enver, additional, Adanir, Haydar, additional, Albhaisi, Somaya, additional, Asrani, Sumeet, additional, Reddy, K. Rajender, additional, Shaw, Jawaid, additional, Vargas, Hugo, additional, Biggins, Scott, additional, Thuluvath, Paul J., additional, Keaveny, Andrew, additional, Hayes, Peter, additional, Torre, Aldo, additional, Idilman, Ramazan, additional, Cao, Zhujun, additional, Álvares-da-Silva, Mario, additional, George, Jacob, additional, Desalegn, Hailemichael, additional, Bush, Brian, additional, Thacker, Leroy, additional, Andres, Duarte Rojo, additional, and Choudhury, Ashok, additional

Published
2023
Full Text
View/download PDF

34. Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Author

Anastasiou, Olympia Aevdoxia, primary, Caruntu, Florin Alexandru, additional, Curescu, Manuela Gabriela, additional, Yalcin, Kendal, additional, Akarca, Ulus S, additional, Gurel, Selim, additional, Zeuzem, Stefan, additional, Erhardt, Andreas, additional, Lüth, Stefan, additional, Papatheodoridis, George, additional, Keskin, Onur, additional, Port, Kerstin, additional, Radu, Monica, additional, Celen, Mustafa, additional, Idilman, Ramazan, additional, Heidrich, Benjamin, additional, Mederacke, Ingmar, additional, von der Leyen, Heiko, additional, Kahlhöfer, Julia, additional, von Karpowitz, Maria, additional, Hardtke, Svenja, additional, Cornberg, Markus, additional, Yurdaydin, Cihan, additional, and Wedemeyer, Heiner, additional

Published
2023
Full Text
View/download PDF

35. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Author

Blach, Sarah, Zeuzem, Stefan, Manns, Michael, Altraif, Ibrahim, Duberg, Ann-Sofi, Muljono, David H, Waked, Imam, Alavian, Seyed M, Lee, Mei-Hsuan, Negro, Francesco, Abaalkhail, Faisal, Abdou, Ahmed, Abdulla, Maheeba, Rached, Antoine Abou, Aho, Inka, Akarca, Ulus, Al Ghazzawi, Imad, Al Kaabi, Saad, Al Lawati, Faryal, Al Namaani, Khalid, Al Serkal, Youssif, Al-Busafi, Said A, Al-Dabal, Layla, Aleman, Soo, Alghamdi, Abdullah S, Aljumah, Abdulrahman A, Al-Romaihi, Hamad E, Andersson, Monique I, Arendt, Vic, Arkkila, Perttu, Assiri, Abdullah M, Baatarkhuu, Oidov, Bane, Abate, Ben-Ari, Ziv, Bergin, Colm, Bessone, Fernando, Bihl, Florian, Bizri, Abdul R, Blachier, Martin, Blasco, Antonio J, Mello, Carlos E Brandão, Bruggmann, Philip, Brunton, Cheryl R, Calinas, Filipe, Chan, Henry L Y, Chaudhry, Asad, Cheinquer, Hugo, Chen, Chien-Jen, Chien, Rong-Nan, Choi, Moon Seok, Christensen, Peer B, Chuang, Wan-Long, Chulanov, Vladimir, Cisneros, Laura, Clausen, Mette R, Cramp, Matthew E, Craxi, Antonio, Croes, Esther A, Dalgard, Olav, Daruich, Jorge R, de Ledinghen, Victor, Dore, Gregory J, El-Sayed, Manal H, Ergör, Gul, Esmat, Gamal, Estes, Chris, Falconer, Karolin, Farag, Elmoubashar, Ferraz, Maria L G, Ferreira, Paulo R, Flisiak, Robert, Frankova, Sona, Gamkrelidze, Ivane, Gane, Ed, García-Samaniego, Javier, Khan, Amir Ghafoor, Gountas, Ilias, Goldis, Adrian, Gottfredsson, Magnús, Grebely, Jason, Gschwantler, Michael, Pessôa, Mário Guimarães, Gunter, Jessie, Hajarizadeh, Behzad, Hajelssedig, Omer, Hamid, Saeed, Hamoudi, Waseem, Hatzakis, Angelos, Himatt, Sayed M, Hofer, Harald, Hrstic, Irena, Hui, Yee-Tak, Hunyady, Bela, Idilman, Ramazan, Jafri, Wasim, Jahis, Rohani, Janjua, Naveed Z, Jarčuška, Peter, Jeruma, Agita, Jonasson, Jón G, Kamel, Yasser, Kao, Jia-Horng, Kaymakoglu, Sabahattin, Kershenobich, David, Khamis, Jawad, Kim, Young S, Kondili, Loreta, Koutoubi, Zaher, Krajden, Mel, Krarup, Henrik, Lai, Moon-sing, Laleman, Wim, Lao, Wai-cheung, Lavanchy, Daniel, Lázaro, Pablo, Leleu, Henri, Lesi, Olufunmilayo, Lesmana, Laurentius A, Li, Michael, Liakina, Valentina, Lim, Young-Suk, Luksic, Boris, Mahomed, Adam, Maimets, Matti, Makara, Mihály, Malu, Abraham O, Marinho, Rui T, Marotta, Paul, Mauss, Stefan, Memon, Muhammad S, Correa, Maria C Mendes, Mendez-Sanchez, Nahum, Merat, Shahin, Metwally, Ammal M, Mohamed, Rosmawati, Moreno, Christophe, Mourad, Fadi H, Müllhaupt, Beat, Murphy, Kimberly, Nde, Helen, Njouom, Richard, Nonkovic, Diana, Norris, Suzanne, Obekpa, Solomon, Oguche, Stephen, Olafsson, Sigurður, Oltman, Marian, Omede, Ogu, Omuemu, Casimir, Opare-Sem, Ohene, Øvrehus, Anne L H, Owusu-Ofori, Shirley, Oyunsuren, Tsendsuren S, Papatheodoridis, George, Pasini, Ken, Peltekian, Kevork M, Phillips, Richard O, Pimenov, Nikolay, Poustchi, Hossein, Prabdial-Sing, Nishi, Qureshi, Huma, Ramji, Alnoor, Razavi-Shearer, Devin, Razavi-Shearer, Kathryn, Redae, Berhane, Reesink, Henk W, Ridruejo, Ezequiel, Robbins, Sarah, Roberts, Lewis R, Roberts, Stuart K, Rosenberg, William M, Roudot-Thoraval, Françoise, Ryder, Stephen D, Safadi, Rifaat, Sagalova, Olga, Salupere, Riina, Sanai, Faisal M, Avila, Juan F Sanchez, Saraswat, Vivek, Sarmento-Castro, Rui, Sarrazin, Christoph, Schmelzer, Jonathan D, Schréter, Ivan, Seguin-Devaux, Carole, Shah, Samir R, Sharara, Ala I, Sharma, Manik, Shevaldin, Anatoly, Shiha, Gamal E, Sievert, William, Sonderup, Mark, Souliotis, Kyriakos, Speiciene, Danute, Sperl, Jan, Stärkel, Peter, Stauber, Rudolf E, Stedman, Catherine, Struck, Daniel, Su, Tung-Hung, Sypsa, Vana, Tan, Soek-Siam, Tanaka, Junko, Thompson, Alexander J, Tolmane, Ieva, Tomasiewicz, Krzysztof, Valantinas, Jonas, Van Damme, Pierre, van der Meer, Adriaan J, van Thiel, Ingo, Van Vlierberghe, Hans, Vince, Adriana, Vogel, Wolfgang, Wedemeyer, Heiner, Weis, Nina, Wong, Vincent WS, Yaghi, Cesar, Yosry, Ayman, Yuen, Man-fung, Yunihastuti, Evy, Yusuf, Aasim, Zuckerman, Eli, and Razavi, Homie

Published
2017
Full Text
View/download PDF

38. Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.

Author

Anastasiou, Olympia E., Caruntu, Florin A., Curescu, Manuela G., Yalcin, Kendal, Akarca, Ulus S., Gürel, Selim, Zeuzem, Stefan, Erhardt, Andreas, Lüth, Stefan, Papatheodoridis, George V., Keskin, Onur, Port, Kerstin, Radu, Monica, Celen, Mustafa K., Idilman, Ramazan, Heidrich, Benjamin, Mederacke, Ingmar, von der Leyen, Heiko, Kahlhöfer, Julia, and von Karpowitz, Maria

Subjects
HEPATITIS D, HEPATITIS D virus, TENOFOVIR, CIRRHOSIS of the liver, HEPATOCELLULAR carcinoma
Abstract

Background & Aims: Until recently, pegylated interferon‐alfa‐2a (PEG‐IFNa) therapy was the only treatment option for patients infected with hepatitis D virus (HDV). Treatment with PEG‐IFNa with or without tenofovir disoproxil fumarate (TDF) for 96 weeks resulted in HDV RNA suppression in 44% of patients at the end of therapy but did not prevent short‐term relapses within 24 weeks. The virological and clinical long‐term effects after prolonged PEG‐IFNa‐based treatment of hepatitis D are unknown. Methods: In the HIDIT‐II study patients (including 40% with liver cirrhosis) received 180 μg PEG‐IFNa weekly plus 300 mg TDF once daily (n = 59) or 180 μg PEG‐IFNa weekly plus placebo (n = 61) for 96 weeks. Patients were followed until week 356 (5 years after end of therapy). Results: Until the end of follow‐up, 16 (13%) patients developed liver‐related complications (PEG‐IFNa + TDF, n = 5 vs PEG‐IFNa + placebo, n = 11; p =.179). Achieving HDV suppression at week 96 was associated with decreased long‐term risk for the development of hepatocellular carcinoma (p =.04) and hepatic decompensation (p =.009). Including complications irrespective of PEG‐IFNa retreatment status, the number of patients developing serious complications was similar with (3/18) and without retreatment with PEG‐IFNa (16/102, p >.999) but was associated with a higher chance of HDV‐RNA suppression (p =.024, odds ratio 3.9 [1.3–12]). Conclusions: Liver‐related clinical events were infrequent and occurred less frequently in patients with virological responses to PEG‐IFNa treatment. PEG‐IFNa treatment should be recommended to HDV‐infected patients until alternative therapies become available. Retreatment with PEG‐IFNa should be considered for patients with inadequate response to the first course of treatment. Clinical Trial registration: NCT00932971. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

40. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study

Author

Kim, Beom Kyung, primary, Bergstrom, Jaclyn, additional, Loomba, Rohan, additional, Tamaki, Nobuharu, additional, Izumi, Namiki, additional, Nakajima, Atsushi, additional, Idilman, Ramazan, additional, Gumussoy, Mesut, additional, Oz, Digdem K., additional, Erden, Ayse, additional, Truong, Emily, additional, Yang, Ju Dong, additional, Noureddin, Mazen, additional, Allen, Alina M., additional, Loomba, Rohit, additional, and Ajmera, Veeral, additional

Published
2023
Full Text
View/download PDF

41. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Author

Bajaj, Jasmohan S, primary, Choudhury, Ashok K, additional, Xie, Qing, additional, Kamath, Patrick S, additional, Topazian, Mark, additional, Hayes, Peter C, additional, Torre, Aldo, additional, Desalegn, Hailemichael, additional, Idilman, Ramazan, additional, Cao, Zhujun, additional, Alvares-da-Silva, Mario R, additional, George, Jacob, additional, Bush, Brian J, additional, Thacker, Leroy R, additional, Wong, Florence, additional, Sarin, Shiv K, additional, Kumar, Shiva, additional, Marciano, Sebastián, additional, Gadano, Adrián, additional, Tudehope, Fiona, additional, Gibson, Robert, additional, Prudence, Alexander, additional, Doyle, Adam, additional, Si, Hooi Ling, additional, Riordan, Stephen, additional, Farias, Alberto, additional, Zitelli, Patricia, additional, Bera, Chinmay, additional, Faisal, Nabiha, additional, Tandon, Puneeta, additional, Dahiya, Monica, additional, Lohoues, Marie Jeanne, additional, Lah, Ponan Claude Regis, additional, Benítez, Carlos, additional, Arrese, Marco, additional, Xian, Yongchao, additional, Guan, Jin, additional, Zhu, Chuanwu, additional, Wang, Yingling, additional, Su, Minghua, additional, Su, Man, additional, Gao, Yanhang, additional, Wang, Xinrui, additional, Jiang, Yongfang, additional, Peng, Feng, additional, Zhao, Caiyan, additional, Wang, Wei, additional, Wang, Lei, additional, Yin, Dedong, additional, Lu, Mingqin, additional, Cai, Yijing, additional, Zhang, Ningping, additional, Zhang, Wanqin, additional, Li, Hai, additional, Dong, Fuchen, additional, Zheng, Xin, additional, Liu, Jing, additional, Tang, Hong, additional, Yan, Libo, additional, Xu, Bin, additional, Wei, Linlin, additional, Gao, Zhiliang, additional, Xu, Zhen, additional, Lin, Minghua, additional, Gao, Haibin, additional, Chen, Jinjun, additional, Li, Beiling, additional, Liu, Chenghai, additional, Zhang, Yanyun, additional, Hu, Peng, additional, Deng, Huan, additional, Belimi, Hibat Allah, additional, Debzi, Nabil, additional, Fisseha, Henok, additional, Aravinthan, Aloysious D, additional, Venkatachalapathy, Suresh Vasan, additional, Rajoriya, Neil, additional, Faulkes, Rosemary, additional, Leith, Damien, additional, Forrest, Ewan, additional, Adebayo, Danielle, additional, Kennedy, James, additional, Yung, Diana, additional, Seto, Wai-Kay, additional, Fung, James, additional, Katchman, Helena, additional, Rabinowich, Liane, additional, Nagral, Aabha, additional, Jhaveri, Ajay, additional, Kulkarni, Anand, additional, Sharma, Mithun, additional, Eapen, C E, additional, Goel, Ashish, additional, Gandotra, Akash, additional, Duseja, Ajay, additional, Saraya, Anoop, additional, Yegurla, Jatin, additional, Rela, Mohamed, additional, Jothimani, Dinesh, additional, Arora, Anil, additional, Kumar, Ashish, additional, Dhiman, Radha Krishan, additional, Roy, Akash, additional, Anand, Anil C, additional, Praharaj, Dibyalochan, additional, Hueso, Sarai Gonzalez, additional, Cabrera, Araceli Bravo, additional, Pérez Hérnandez, José Luis, additional, Gutierrez, Oscar Morales, additional, Miranda Zazueta, Godolfino, additional, Ramos-Pineda, Abraham, additional, Castillo Barradas, Mauricio, additional, Velazquez, Rene Male, additional, Made, Lilian Torres, additional, Velarde-Ruiz Velasco, José Antonio, additional, Félix-Tellez, Francisco, additional, Cordova-Gallardo, Jacqueline, additional, Rajaram, Ruveena, additional, Nik Muhamad Afendi, Nik Arsyad, additional, Okeke, Edith N, additional, Nyam, David P, additional, Allam, Dalia, additional, Kumar Patwa, Yashwi Haresh, additional, Tan, Hiang Keat, additional, Liou, Wei Lun, additional, Treeprasertsuk, Sombat, additional, Wejnaruemarn, Salisa, additional, Haktaniyan, Busra, additional, Gunduz, Feyza, additional, Aslan, Rahmi, additional, Yildirim, Abdullah Emre, additional, Barutcu, Sezgin, additional, Karasu, Zeki, additional, Uysal, Alper, additional, Ucbilek, Enver, additional, Kosay, Tolga, additional, Adanir, Haydar, additional, Dinçer, Dinç, additional, Albhaisi, Somaya, additional, Asrani, Sumeet, additional, Fallahadeh, Mohammad Amin, additional, Reddy, K Rajender, additional, Rahematpura, Suditi, additional, Shaw, Jawaid, additional, Vargas, Hugo E., additional, Bayne, David, additional, Biggins, Scott W, additional, Filipek, Natalia, additional, Thuluvath, Paul, additional, Sheshadri, Somya, additional, Keaveny, Andrew, additional, Duarte Rojo, Andres, additional, and Cabello Negrillo, Ricardo, additional

Published
2023
Full Text
View/download PDF

42. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

Author

Papatheodoridis, George, Dalekos, George, Sypsa, Vana, Yurdaydin, Cihan, Buti, Maria, Goulis, John, Calleja, Jose Luis, Chi, Heng, Manolakopoulos, Spilios, Mangia, Giampaolo, Gatselis, Nikolaos, Keskin, Onur, Savvidou, Savvoula, de la Revilla, Juan, Hansen, Bettina E., Vlachogiannakos, Ioannis, Galanis, Kostantinos, Idilman, Ramazan, Colombo, Massimo, Esteban, Rafael, Janssen, Harry L.A., and Lampertico, Pietro

Published
2016
Full Text
View/download PDF

44. Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver.

Author

Özaslan, Ersan, Günşar, Fulya, Örmeci, Aslı Çiftçibaşı, Hatemi, İbrahim, Efe, Cumali, Akyol, Gülen, Turhan, Nesrin, Barbet, Funda Yılmaz, Sağol, Özgül, Çelikel, Çiğdem Ataizi, Güllüoğlu, Mine, Gökçe, Dilara Turan, İstemihan, Zülal, Eşkazan, Tuğçe, and İdilman, Ramazan

Published
2023
Full Text
View/download PDF

45. Non‐invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta

Author

Kalkan, Çağdaş, primary, Yılmaz, Yusufcan, additional, Erdoğan, Beyza Doğanay, additional, Savaş, Berna, additional, Yurdcu, Esra, additional, Çalışkan, Aysun, additional, Keskin, Onur, additional, Gencdal, Genco, additional, Zeybel, Müjdat, additional, Törüner, Murat, additional, Bozdayi, A. Mithat, additional, Idilman, Ramazan, additional, and Yurdaydin, Cihan, additional

Published
2023
Full Text
View/download PDF

48. A Combination Of Non-Invasive Tests In Detection Of NAFLD-Related Advanced Fibrosis Is Not Superior To MRE Alone

Author

Duman, Serkan, additional, Gümüşsoy, Mesut, additional, Kuru, Diğdem, additional, Kiremitci, Saba, additional, Gökcan, Hale, additional, Bodakçı, Emin, additional, Melekoğlu, Zeynep, additional, Ulaş, Bahar, additional, Elhan, Atilla, additional, Savaş, Berna, additional, Erden, Ayşe, additional, and İdilman, Ramazan, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results